Correlation Between Beta Drugs and Mangalam Drugs

Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Mangalam Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Mangalam Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beta Drugs and Mangalam Drugs And, you can compare the effects of market volatilities on Beta Drugs and Mangalam Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Mangalam Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Mangalam Drugs.

Diversification Opportunities for Beta Drugs and Mangalam Drugs

-0.63

Correlation Coefficient

Beta Drugs  Mangalam Drugs

Excellent diversification

The 3 months correlation between Beta and Mangalam is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Mangalam Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangalam Drugs And and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Mangalam Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangalam Drugs And has no effect on the direction of Beta Drugs i.e., Beta Drugs and Mangalam Drugs go up and down completely randomly.

Pair Corralation between Beta Drugs and Mangalam Drugs

Assuming the 90 days trading horizon Beta Drugs is expected to generate 1.31 times more return on investment than Mangalam Drugs. However, Beta Drugs is 1.31 times more volatile than Mangalam Drugs And. It trades about 0.11 of its potential returns per unit of risk. Mangalam Drugs And is currently generating about -0.03 per unit of risk. If you would invest  175,770  in Beta Drugs on September 2, 2024 and sell it today you would earn a total of  41,415  from holding Beta Drugs or generate 23.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

Beta Drugs  vs.  Mangalam Drugs And

Beta Drugs

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Mangalam Drugs And

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Mangalam Drugs is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Beta Drugs and Mangalam Drugs

The main advantage of trading using opposite Beta Drugs and Mangalam Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Mangalam Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangalam Drugs will offset losses from the drop in Mangalam Drugs' long position.

The idea behind Beta Drugs and Mangalam Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..